Vimarsana
Biggest News Aggregation in the World

Eva Mistry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eva Mistry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eva Mistry Today - Breaking & Trending Today

UC taking part in national stroke study to give patients more options - Vimarsana News

UC taking part in national stroke study to give patients more options

Local researchers have just launched a new study, which could provide a new treatment to help in stroke recovery.

UC Gardner Neuroscience Institute to Lead New National Stroke Study - Vimarsana News

UC Gardner Neuroscience Institute to Lead New National Stroke Study

SISTER study to test efficacy of new treatment for acute ischemic stroke

University of Cincinnati to lead NIH StrokeNet for next five years - Vimarsana News

University of Cincinnati to lead NIH StrokeNet for next five years

The University of Cincinnati and UC Health have been renewed as the National Coordinating Center of the National Institutes of Health (NIH) StrokeNet, which is the primary infrastructure for multicenter trials of stroke funded by NIH and the pipeline for new potential treatments for adults and children with stroke and those at risk for stroke.

Post-Clot Removal Blood Pressure Reduction Raises Safety Concerns - Vimarsana News

Post-Clot Removal Blood Pressure Reduction Raises Safety Concerns

Using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe.

BEST II Clinical Trial Findings Reported at International Stroke Conference: Proceed with Caution on Blood Pressure Meds after Clot Removal - Vimarsana News

BEST II Clinical Trial Findings Reported at International Stroke Conference: Proceed with Caution on Blood Pressure Meds after Clot Removal

Lowering blood pressure after clot removal may not be safe, and should be individualized, according to findings of the BEST II Trial presented during the American Stroke Association International Stroke Conference.